Notably, the inhibition of HSP90 has been observed to decrease the production of significant pro-inflammatory cytokines, including IL-1β, IL-6, CXCL10, and tumor necrosis factor (TNF), which are implicated in the progression of COVID-19. Here, TNF is linked to COVID-19.